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Abstract Breast reduction is a highly emotional topic,
involving three conflicting interests: (a) women suffering
from symptomatic macromastia, (b) health insurance
companies, and (c) surgeons. Many insurance compa-
nies, including those in Austria, cover (if at all) only
breast reductions with a minimum resection weight of
500 g per breast, irrespective of the physical build of the
woman involved. We retrospectively reviewed 136 pa-
tients’ charts from both cosmetic and reconstructive
breast reduction operations and compared the breast re-
section weight to various parameters of body proportions
such as height, weight, body mass index (BMI), and
body surface area to determine the parameter best corre-
lated to the weight of breast tissue resected. From this
we developed a graded scale for guiding future opera-
tions irrespective of a woman’s body build. The resec-
tion weight ranged from 55 to 1530 g (mean 450±266,
median 406); mean BMI was 25.1. The arbitrary 500 g
breast resection rule discriminates against women of
nonaverage weight or height: of 24 patients (18%) with a
cosmetic indication 4 had more than 500 g breast tissue
resected bilaterally, while in 62 reconstructive patients
(46%) less than the arbitrary 500 g breast tissue was re-
sected. The parameter best correlated to the mean weight
of breast tissue resected (sum of both breasts) was BMI.
We therefore suggest using the BMI as the basis for a
graded weight resection guideline for reconstructive
breast reductions. The BMI-based scale treats equally
women of all types of body build. In women with a BMI
greater than 30 (classified as adiposity) we recommend
that breast reduction be postponed, and a general body
weight reduction program be undertaken for the sake of
a higher impact on general well-being.
Keywords Breast reduction · Body mass index · Breast
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Introduction
Breast reduction is the most common operation on the
female breast in plastic surgery, with a rate of up to 9.5
in 100,000 women [12]. The amount of breast tissue re-
moved varies widely and ranges from 30 g to 4 000 g or
more per breast [14]. There is general agreement that hy-
pertrophied breasts, in which the weight of the resected
tissue reaches up to 4000 g, is a highly pathological con-
dition; doubtless such reduction operations have a medi-
cally indicated, predominantly reconstructive character
and should be covered by insurance companies. The
medical indication is less clear when breast hypertrophy
is less pronounced. Strombeck [19], in a survey of 1,220
women, defined breast hypertrophy, or macromastia, as a
50% increase in the proposed normal size of a breast of
400 g. Other authors [2, 10] use as a practical rule of
thumb the borderline between normal and hypertrophied
breasts as a bra cup size of D. Yet the definition of breast
hypertrophy has always been somewhat vague since it
cannot be considered as an absolute size or number, in-
dependently of body proportions.
Another ill-defined term is macromastia, which was
initially used synonymously with the term breast hyper-
trophy (i.e., to denote a breast weighing 600 g or more
[19]) but is now used mainly to differentiate between hy-
pertrophied breasts and “normal large breasts.” Macro-
mastia in this definition is characterized by the presence
of persistent, painful, physical breast-related symptoms,
irrespective of absolute breast size, age, body weight,
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and height [6]. Dabbah et al. [4] in contrast, use the term
macromastia to describe breasts which the patient feels
to be too large for her physical proportions, thus causing
physical and/or emotional disturbances, and in which
case a reduction would provide functional relief regard-
less of the amount of breast tissue removed. Breast-relat-
ed symptoms include a broad variety of complaints such
as breast pain, chest pain, shoulder pain, upper and lower
back and neck strain, shoulder grooving, headache, arm
pain, ulnar paresthesia, and intertrigo; the symptoms can
be present alone or in combination [10]. Other psycho-
logical, social, and cosmetic complaints are poor pos-
ture, inability to participate in physical activities, fatigue,
breast sagging (91% [6]), poorly fitting clothes, unac-
ceptable appearance, feeling of deformity, and lowered
self-esteem.
In the majority of recent studies [2, 4, 6, 9, 13] there is
general agreement that symptomatic macromastia produc-
es a physical and psychological burden, and that breast re-
duction leads to both a significant reduction in pain symp-
toms and a very high satisfaction rate. Additionally, psy-
chological studies have demonstrated improvement in
self-esteem and self-confidence. In a retrospective study
on 406 patients [6] the primary reason for breast reduction
(80% with more than 800 g tissue removed per breast)
was the relief of breast-related symptoms (91%), followed
by feelings of self-consciousness due to the size of their
breasts (78%), and cosmetic concern (65%). No woman
listed cosmetic concern alone as her primary motivation.
In either case, whether the operation is primarily recon-
structive or cosmetic, there are valid reasons for plastic
surgeons to perform breast reductions.
From the point of view of insurance companies, how-
ever, this differentiation is the key point in their decision
whether to reimburse the costs of the operation, as most
of them exclude cosmetic procedures in their contracts.
The differentiation between purely esthetic and recon-
structive indications is, especially at or below a resection
weight of 500 g per breast, unclear, and decisions are
necessarily somewhat arbitrary since “true motivations”
are difficult or impossible to quantify in a scientific way.
Apart from those insurance companies that do not cover
the procedures at all, there are companies that define
predicted specimen weights under 700 g on each side as
“purely” esthetic cases [8] and others that demand docu-
mented radiographic confirmation of skeletal problems
stemming from large breasts [16]. Most companies (in-
cluding those in Austria) reimburse the cost of a resec-
tion involving more than 500 g tissue per breast, provid-
ed that the patient is not more than 10% above ideal
body weight or adipose. Schnur et al. [16] attempted to
determine more measurable criteria and to establish an
algorithm to differentiate between cosmetic and recon-
structive breast reductions. They plotted the logarithm of
the tissue weight removed from the right breast against
the body surface area (n=600), and declared (on the basis
of the opinion of 132 plastic surgeons) operations below
the 5th percentile to be purely cosmetic and those above
the 22nd percentile to be reconstructive.
Despite this and other attempts to define a scientific
basis there continue to be three conflicting interest
groups on the topic of breast reductions: (a) women who
suffer from symptomatic macromastia and wish to have
their breast reduction to enhance their somatic, and psy-
chological well-being paid for by the insurance compa-
ny, irrespective of the resection weight, (b) the insurance
companies, which are ready to pay only for genuinely
medically indicated operations and who claim that the
available money should be divided economically, not for
the maximum benefit of a single patient but for the opti-
mum benefit of all patients (which definitely excludes
cosmetic breast reductions at the moment), and (c) the
surgeons who try to provide a fair, scientific basis to dif-
ferentiate between cosmetic and reconstructive indica-
tions of breast reduction for the sake of both patients and
the insurance companies.
In the western part of Austria, whether a breast reduc-
tion is defined as cosmetic or reconstructive lies primari-
ly in the hands of the plastic surgeons; the general guide-
lines of the insurers require that macromastia be symp-
tomatic, and that more than 500 g breast tissue on each
side in nonobese women be removed. Concerned about
possible discrimination involved in such a global, gener-
alized rule, we undertook a retrospective review of our
patients’ charts to examine the breast resection weight in
relation to various parameters of the body proportions
such as height, weight, body mass index (BMI), and
body surface area (BSA). In the case of a significant dis-
crimination of women of nonaverage weight or height,
the aim of our study was either to recommend one of the
few existing algorithms [17, 18] or to provide a new ob-
jective, measurable, and reproducible scaled guideline,
one adapted to the individual patient’s body proportions
to differentiate between reconstructive and cosmetic in-
dications for breast reduction, beyond the “500 g resec-
tion rule.”
Patients and methods
All patients who had a bilateral breast reduction at our clinic be-
tween April 1997 and December 2001 were included in this study
[1]. Breast reduction was defined as an operation that removed fat
or breast tissue beyond the epidermis and dermis, irrespective of
the amount of tissue involved. The patients were asked questions
concerning their general health status, their height and weight,
their complaints, and their motivations for breast reduction. Apart
from determining the jugular notch to nipple distance, the inter-
nipple distance and the position of the nipple in relation to the up-
per arm, no further measurements on the thorax or the volume of
the breast were made.
The differentiation between cosmetic and reconstructive breast
reduction (i.e., less or more than 500 g) was decided in the end by
one of the two most experienced surgeons and depended on the
volume of the breast in relation to the body configuration. If the
differentiation between cosmetic and reconstructive seemed bor-
derline, the patients had to obtain permission also from their insur-
ance company for coverage. This was the case in five patients
(3.7%). In the cases in which both the surgeon and the insurance
company were of the opinion that the breast reduction was solely
cosmetically motivated, the patient had to pay for the breast reduc-
tion herself. Patients with obvious adiposity had already been re-
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jected as operation candidates by the surgeons. “Overweight” was
defined retrospectively as a body mass index (BMI) between 25
and 29.9 and “adiposity” as a BMI higher than 30 [7]. The weight
of resected breast tissue on each side was obtained from measure-
ments in the operating room and verified by a pathologist.
For the statistical analysis the “mean” resection weight was de-
rived from the combined specimens of both breasts. The decade
logarithm of the mean resection weight was plotted against the
BMI and the percentiles of residuals were used to construct the 5th
and 22nd percentile lines. Results were analyzed using StatView
5.0.1. (SAS Institute, Cary, N.C., USA) and SPSS (version 11.0,
SPSS, Chicago, Ill., USA). Continuous variables are summarized
as mean ±SD. Nominal variables are presented in terms of abso-
lute numbers and percentages. The comparison of various vari-
ables between the cosmetic and the reconstructive group was car-
ried out by the Mann-Whitney test. Correlations between the vari-
ous height/weight parameters were indicated by Spearman’s rank
correlation. P values of 0.05 or less were considered significant.
Results
Of 165 consecutive patients with breast reductions, 136
could be included in the study. The resection weight
ranged from 55 to 1530 g per breast (mean 450±266,
median 406). Fifty-five patients (40%) had a resection
weight of less than 350 g and 86 (63%) less than 500 g.
In contrast, 22 (16%) patients had more than 700 g re-
section weight per breast. (36% classified as overweight,
7.5% as adipose). Mean BMI was 25.1. Table 1 presents
the physical data of the patients. Twenty-four patients
(18%) were classified a priori as undergoing the opera-
tion for cosmetic indications; these patients paid for the
breast reduction themselves. In these patients the resec-
tion weight was significantly less than in the group
whose operation was paid for by the insurer (mean resec-
tion weight 290 g vs. 490 g, P<0.001). Also mean body
weight, BMI, and BSA were significantly lower in the
“cosmetic” group: 25% of patients were overweight and
no woman was adipose. Nevertheless, four of these
women (17%) had a mean resection weight of more than
500 g. In the “reconstructive” group (n=112) less than
the predicted 500 g of breast tissue was resected in 62
patients (46%). Forty-three of the patients (32%) in the
“reconstructive” group were overweight and seven adi-
pose. The BMI (all patients together) was correlated to
the mean weight of resected breast tissue (r=0.64,
P≤0.001), patient’s weight (r=0.57, P≤0.001), and BSA
(r=0.48, P≤0.001).
The decadic logarithmized mean resection weight was
plotted against the BMI according and similar to the
Schnur et al. [16] scheme, and the 5th and the 22nd per-
centiles of BMI were drawn in. This yielded a group of
101 patients (74%) fulfilling the criteria of the insurance
companies in our country for a reconstructive breast re-
duction, i.e., BMI less than 30 (nonadipose patients)
above the 22nd percentile. Using the more stringent re-
quirements of a BMI less than 25 (nonoverweight pa-
tients) and the 22nd percentile, only 46 patients (34%)
would be characterized as requiring reconstructive sur-
gery. The combination of a BMI less than 25 and the 5th
percentile as cutoff point would leave 53 patients (39%)
in the “reconstructive group.”
Figure 1 shows the application of the modified
Schnur et al. [16] algorithm to our patient population.
With this scale the range of breast reductions considered
as reconstructive would reach from 83 g at a BMI of 15
to 832 g at a BMI of 35.
Table 1 Physical data of all 136 breast reduction patients. The 
data are listed for the group as a whole, and also according to
whether the indication was judged as cosmetic or reconstructive
(BMI body mass index, BSA body surface area, CI cosmetic indi-
cation, RI reconstructive indication)
All women CI (n=24) RI (n=112) P
Mean ±SD Range Mean ±SD Range Mean ±SD Range
Age 33±13 16–76 37±16 17–76 33±12 16–69 0.45
Height (cm) 163±6 148–180 161±6 148–172 164±7 150–180 0.15
Weight in (kg) 66±11 42–98 61±8 42–74 68±11 49–98 0.007
BMI (kg/m2) 25.1±3.5 19.2–37.5 23.3±2.6 18.4–27.2 25.3±3.6 19.5–37.5 0.003
BSA (m2) 1.72±0.14 1.32–2.07 1.64±0.11 1.32–1.81 1.73±0.14 1.43–2.07 0.007
Fig. 1 The modified Schnur et al. [16] algorithm (BMI instead of
BSA) applied to our patient population. The logarithmized com-
bined specimen weights were plotted against the BMI (linear spec-
imen weights would lead to a regression line negative for small
BMI values): the 5th and the 22nd percentile line were added. The
BMI of 25 and the BMI of 30 were marked vertically. The gray
area marking the region above the 22nd percentile with a BMI
greater than 30 defines the population fitting the Schnur et al. defi-
nition for a reconstructive breast reduction. The 22nd percentile
line suggests the following breast reduction weights should be
covered by insurers for the following representative BMI’s: BMI
of 15: >83 g; BMI of 20: >148 g; BMI of 25: >263 g; BMI of 30:
>468 g; BMI of 35: >832 g
Discussion
Our retrospective review showed an overweight rate of
more than one-third, an adiposity rate of 7.5%, and that
nearly one-half of our patients had less than the mandat-
ed 500 g breast tissue resected. These data demonstrate
that basing the differentiation between “reconstructive”
and “cosmetic” breast reduction (and the resulting issue
of insurance coverage) on a standardized resection
weight or the body weight of the patient alone, leads to
many false-positive and false-negative decisions. Other
authors report similar difficulty; in 31 of 100 patients it
was not possible to determine in advance whether the 
insurance company’s requirements would be met [18].
We are convinced that every responsible plastic sur-
geon, given the choice of resecting the “necessary
amount” of breast tissue to fulfill the criteria for insur-
ance coverage or shaping a beautiful breast that is not
too small for the body build, would choose the latter op-
tion. While the resection weight is still probably the
most objective criterion to differentiate between cosmet-
ic and reconstructive indications for breast reductions,
our results show that the 500-g rule is very disadvanta-
geous to small, slim women and advantageous to adipose
women. This bias was obviously also the reason why
Schnur et al. [16] introduced their BSA-based algorithm.
If similar criteria were applied to our series (Fig. 1),
there would be a range of reconstructive resections
weights from 80 g to 830 g within the 15–35 BMI range.
We would not regard a resection weight of 80 g breast
tissue as curative in any women.
A further controversial point in the study by Schnur et
al. is the fact that the 5th and 22nd percentiles as cutoff
points were established empirically on the basis of the
opinion of 132 plastic surgeons as to how many women
have their breasts reduced for purely cosmetic or recon-
structive purposes. Doubtless this conclusion can be a
source of bias; the authors themselves state that these are
“soft data.” Seitckik [18] states that it is impossible to
construct a useful formula for verifying subjective com-
plaints of discomfort or the prospect of their relief by
surgery based on body dimension or specimen weight
alone. He suggests a graded minimum specimen weight
standard: 200 g per breast for body weight less than
60 kg; 350 g for body weight of 61–79 kg; and 500 g for
body weight greater than 80 kg. As this recommendation
relies on the body weight alone and does not consider
body build, such a rule would disadvantage tall women.
For this reason we would not wish to use this recommen-
dation.
Our guideline, also based on an arbitrary, stepwise
minimum resection weight proposal, relies instead on
BMI, which is the variable most closely correlated to
body build in our patients. The BMI must be calculated
in any case for the health insurance companies prior to
surgery to determine whether the patient is of normal
weight, overweight, or adipose. For our algorithm we de-
cided that the required minimum 500 g resection weight
was appropriate to be correlated to the mean BMI of 25.
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Beneath the BMI of 25 the required resection weight
would be lower, and above a BMI of 25 it should be
higher (Table 2). Such a simple, graded scale handles all
women, including those who are small or tall or slim,
fairly, and overweight and adipose women are motivated
to reduce weight before breast reduction.
Overweight or adiposity seems to be significantly
correlated with breast hypertrophy [15]. A prospective
study [9] in 39 women on improving symptoms of mac-
romastia by breast reduction found a mean BMI of 28.5,
compared to a value of 22.3 in a control group of 40 fe-
male volunteers. Another survey [6] came to the same
conclusion: 60% of 406 women were 5–10 kg over their
ideal body weight, and the size of breast reduction was
significantly correlated with excess body weight
(P<0.001). Similarly, Kerrigan et al. [10] compared three
groups of women in a very interesting study on 486 pa-
tients from a broad geographic region in the United
States: women with breast hypertrophy who seek surgi-
cal treatment, women with breast hypertrophy who do
not seek surgical treatment, and women without breast
hypertrophy. The authors found a significantly different
(P≤0.001) mean BMI between the first two groups (>30,
i.e., adipose) and the latter group (BMI of 24.9), and 
this difference was significantly correlated with lower
(P=0.004) comorbid conditions in the normal group. In
addition, patients had to complete self-reported question-
naires, including the European Quality of Life, McGill
Pain Questionnaire, Multidimensional Body-Self Rela-
tions Questionnaire, the Short Form-36 Questionnaire,
and “breast-related symptoms.” Patients with breast hy-
pertrophy who did not seek operation had significantly
better scores than the surgical candidates yet significant-
ly worse scores than the normal control subjects.
Not only macromastia but also associated adiposity
seems to be a considerable health burden; sometimes it 
is difficult to distinguish between the symptoms of the
two. Damush et al. [5], for example, found a significant
impact of BMI on changes in health-related quality of
life in a prospective longitudinal study on 7895 adults.
Coakley et al. [3] concluded from a cross-sectional study
Table 2 BMI-related scale of individual specimen weight limits
for a reconstructive indication (for health insurance purposes) in
breast reduction operations in macromastia (note the much broader
range of correlated breast resection weights in the Schnur et al. 
algorithm in Fig. 1). This scheme derives from an arbitrary multi-
step scale, beginning with a BMI of 15 and a resection weight of
300 g, and proceeding with 0.5 steps in the BMI scale and 10 g
steps in the resection weight scale
BMI g
15–20 (underweight) >300
20–25 >400
25–30 (overweight) >500
30–35 (adiposity)a >600
>35 >700
a From a BMI of >30 onwards, breast reduction is deferred in 
favor of general weight reduction
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on 5,610 women that adiposity is associated with lower
activity levels, with lower feelings of well-being, and a
greater burden of pain (Short Form-36 questionnaire)—
symptoms that also resemble breast-related symptoms.
Despite this proven knowledge, in countries with a high
percentage of adipose women there is a tendency to de-
fine breast reductions as a medical necessity, irrespective
of the resection weight or the BMI [11]. In our country
we think that women with a BMI higher than 30 would
benefit more from a weight reduction program paid by
the insurance companies than from a breast reduction
alone.
In conclusion, we propose using the BMI as the basis
for a graduated, fair weight resection standard for recon-
structive breast reductions. If BMI is higher than 30,
breast reduction should be postponed in favor of general
weight reduction, whenever possible, for the sake of a
higher impact on general well-being. Our algorithm, al-
though arbitrary, is based solely on objective data and
thus avoids individual subjective biases and the difficul-
ty of trying to quantify breast- (or adiposity-) related
pain syndromes. The BMI-based algorithm respects the
fact that women have many different types body build,
and treats all types fairly.
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